"#000000","#ffffff","#10222c","#287da4","#5a8128","#484848","#626262","#bbbdbf","#f69320","#f06724","#00838a","#008b93","#5cc9f3","#2a3b8f","#1b1b1b","#3e3e3e","#148e95","#008b92","#f6931f","#f06724","#2a3b8f","#282d77","#55a0d0","#3192c1"
Home
Careers
Contact Us
YouTube
LinkedIn
Menu
Our Products
Branded Oral Liquids
CaroSpir®
Injectables
Potassium Phosphates Injection, USP
Generic & Non-Prescription
SPS® (Sodium Polystyrene Sulfonate) Suspension
Oracit®
Isoniazid Oral Solution
Sodium Polystyrene Sulfonate Powder
Absorbase®
Dermacloud™
Petrolatum™
Sorbitol Solution USP, 70%
Licensing Opportunities
Our Company
Our Legacy
Our Leadership
Markets We Serve
Resources
CMP Support Services
Resource Library
Risks and Concerns of Crushing & Compounding
Living With Dysphagia
News
Search website
Search
News
Category: Uncategorized
Home
|
--
News
CMP Pharma’s Potassium Phosphates Injection Receives FDA Shelf Life Extension for Specific Lots
CMP Pharma, Inc. Announces Unit Dose Packaging for CaroSpir
®
, The First and Only FDA-Approved Spironolactone Oral Suspension
First FDA approved Potassium Phosphates Injection from CMP Pharma Is Now Available
First FDA approved Potassium Phosphates Injection from CMP Pharma Has Been Approved
CMP Pharma, Inc Announces That CaroSpir
®
, The First And Only FDA-Approved Spironolactone Oral Suspension, Is Now Available
CMP Pharma, Inc. Announces FDA Approval of CaroSpir
®
(Spironolactone Oral Suspension, 25 mg/5 mL)
CMP Pharma and Generic Specialty Pharma Sign Product Development Agreement
TRIANEX
®
0.05%(Triamcinolone Acetonide Ointment,USP) Now Available from Promius Pharma
®
, LLC
Carolina Medical Products Now CMP Pharma
CMP Pharma and Kiel Laboratories Sign Development Agreement for Two NDA Products